BitFrontier Capital Holdings, Inc. Appoints Dr. Jordan P. Balencic as CEO to Lead Strategic Turnaround

BitFrontier Capital Holdings, Inc. (OTC: BFCH) has appointed Dr. Jordan P. Balencic as its Chief Executive Officer, signaling a strategic shift towards health innovation and functional wellness technologies. Dr. Balencic, a physician entrepreneur with extensive experience in the health and wellness sector, aims to realign the company's capital structure and business model to enhance shareholder value.

The company's turnaround strategy includes eliminating over $2 million in legacy convertible note obligations to improve its capital structure. BFCH is pivoting towards consumer health innovation, targeting areas such as functional foods, nootropic beverages, supplements, and digital health technologies. A corporate rebranding initiative is also underway to reflect this new strategic direction.

Further plans involve optimizing the capital structure by streamlining the share structure and reducing the authorized share count. Governance reforms are being implemented, including the assembly of a new Board of Directors to support the company's transition. BFCH intends to pursue OTCQB qualification in 2026, aiming to build investor confidence and access institutional capital.

Dr. Balencic emphasized the disciplined and transparent approach to rebuilding BFCH into a credible, innovation-focused public company. The company's strategic actions are subject to corporate and regulatory approvals, with updates to be published through the OTC Markets Disclosure & News Service.